SLS 8-K 2026-07-27

SELLAS Life Sciences Group, Inc. (SLS) 8-K dated 2026-07-27 — accession 0001104659-26-087110. This URL is the filing, not the SLS hub.

SELLAS Life Sciences Group, Inc. (SLS) is a biotechnology company listed on US.

SELLAS Life Sciences Group, Inc. filed a 8-K on 2026-07-27. Accession 0001104659-26-087110.

Cached items: 2.02, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$18.0M. SLS currently screens at market cap $1.62B.

Not investment advice. The SLS SEC hub lists recent forms. The stock page is the research view.